Skip to main content
. 2010 Oct 5;103(9):1415–1421. doi: 10.1038/sj.bjc.6605935

Figure 2.

Figure 2

Frequencies of PBMC subsets during treatment with oxaliplatin/capecitabine and DC vaccination. Means with s.d. are depicted. (A) Total T cells (CD3+). (B) T helper cells (CD4+). (C) Cytotoxic T cells (CD8+). (D) Natural killer cells (CD3-/CD56+). (E) Monocytes (CD14+). (F) B cells (CD19+).